Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct;72(4):538-546.
doi: 10.1053/j.ajkd.2018.04.023. Epub 2018 Jul 18.

Biological Variability of Estimated GFR and Albuminuria in CKD

Collaborators, Affiliations

Biological Variability of Estimated GFR and Albuminuria in CKD

Sushrut S Waikar et al. Am J Kidney Dis. 2018 Oct.

Abstract

Rationale & objective: Determining whether a change in estimated glomerular filtration rate (eGFR) or albuminuria is clinically significant requires knowledge of short-term within-person variability of the measurements, which few studies have addressed in the setting of chronic kidney disease.

Study design: Cross-sectional study with multiple collections over less than 4 weeks.

Setting & participants: Clinically stable outpatients with chronic kidney disease (N=50; mean age, 56.8 years; median eGFR, 40mL/min/1.73m2; median urinary albumin-creatinine ratio (UACR), 173mg/g).

Exposure: Repeat measurements from serially collected samples across 3 study visits.

Outcomes: Measurements of urine albumin concentration (UAC), UACR, and plasma creatinine, cystatin C, β2-microglobulin (B2M), and beta trace protein (BTP).

Analytical approach: We calculated within-person coefficients of variation (CVw) values and corresponding reference change positive and negative (RCVpos and RCVneg) values using log-transformed measurements.

Results: Median CVw (RCVpos; RCVneg) values of filtration markers were 5.4% (+16%; -14%) for serum creatinine, 4.1% (+12%; -11%) for cystatin C, 7.4% (+23%; -18%) for BTP, and 5.6% (+17%; -14%) for B2M. Results for albuminuria were 33.2% (+145%; -59%) for first-morning UAC, 50.6% (+276%; -73%) for random spot UAC, 32.5% (+141%; -58%) for first-morning UACR, and 29.7% (124%; -55%) for random spot UACR. CVw values for filtration markers were comparable across the range of baseline eGFRs. CVw values for UAC and UACR were comparable across the range of baseline albuminuria values.

Limitations: Small sample size limits the ability to detect differences in variability across markers. Participants were recruited and followed up in a clinical and not research setting, so some preanalytical factors could not be controlled.

Conclusions: eGFR markers appear to have relatively low short-term within-person variability, whereas variability in albuminuria appears to be high, making it difficult to distinguish random variability from meaningful biologic changes.

Keywords: Albuminuria; beta trace protein (BTP); biological variability; biomarker; clinically meaningful differences; coefficient of variation (CV); cystatin C; estimated glomerular filtration rate (eGFR); filtration marker; intraindividual variation; kidney function; laboratory measurement; reproducibility; serum creatinine; urinary albumin-creatinine ratio (UACR); β(2)-microglobulin (B2M).

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Scatterplots of within-person coefficients of variation (CVs) for filtration markers (creatinine, cystatin C, beta trace protein [BTP], and β2-microglobulin [B2M]) against mean values for each marker. Two individuals (highlighted in red and blue circles) had high levels of variability across all four makers.
Figure 2.
Figure 2.
Scatterplots of within-person coefficients of variation (CVs) for random and first-void albuminuria (urine albumin concentration [UAC] and urinary albumin-creatinine ratio [UACR]) against mean values of UAC and UACR.

References

    1. Coresh J, Selvin E, Stevens LA, et al. Prevalence of chronic kidney disease in the United States. JAMA. 2007;298(17):2038–204. - PubMed
    1. Murphy D, McCulloch CE, Lin F, et al. Trends in prevalence of chronic kidney disease in the United States. Ann Intern Med. 2016;165(7):473–481. - PMC - PubMed
    1. Levey AS, Inker LA, Coresh J. GFR estimation: from physiology to public health. Am J Kidney Dis. 2014;63(5):820–834. - PMC - PubMed
    1. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013;3:1–150.
    1. Inker LA, Levey AS, Pandya K, Stoycheff N, Okparavero A, Greene T. Early change in proteinuria as a surrogate end point for kidney disease progression: an individual patient metaanalysis. Am J Kidney Dis. 2014;64(1):74–85. - PMC - PubMed

Publication types

MeSH terms